Tick-borne disease

Project Lyme Harnesses the Power of Public Service Announcements to Inform Parents Their Child's Complex Illness Could Be Lyme

Retrieved on: 
水曜日, 5月 8, 2024
Myalgia, Risk, CDC, Health, Arthralgia, DSM-IV codes, Parent, Depression, Conditional sentence, Tic disorder, Pressure, Patient, Lyme disease, Headache, Fatigue, Irritability, Lymph, Multimedia, Diagnosis, Infection, Fever, Anxiety, Approximation error, PSAS, Tick-borne disease, Deficit spending, Heart failure, Pharmaceutical industry

NEW YORK, May 8, 2024 /PRNewswire/ -- The CDC now estimates nearly half a million people will contract Lyme disease in the United States each year. However, most people do not realize how Lyme disease can cause diverse, devastating symptoms in some patients. The range of symptoms is expansive and often overwhelming, from flu-like symptoms such as fatigue, fever, enlarged lymph nodes, headaches, muscle aches, and joint pain in the early stages to more serious issues such as cognitive impairment, sleep problems, mood changes, shortness of breath or heart failure when a diagnosis is missed or delayed. Lyme has been reported in all 50 states, with case counts increasing throughout the country. As the risk of contracting a tick-borne infection increases nationally, it is imperative to educate a broader audience, especially parents of young children.

Key Points: 
  • However, most people do not realize how Lyme disease can cause diverse, devastating symptoms in some patients.
  • Children are at the greatest risk of contracting Lyme disease and delayed diagnosis can prevent them from living a normal life.
  • In their new PSAs , Project Lyme tells the stories of Rylyn and Pippa , two young children who are recovering from Lyme disease.
  • Project Lyme's PSAs provide advice that if you are unsure of the source of your child's illness, it could be Lyme.

Center for Lyme Action Applauds New National Vector Borne Disease Strategy

Retrieved on: 
水曜日, 2月 14, 2024
Brightness, Tick, Lyme disease, Federation, Notifiable disease, Disease, Dissemination, VBD, Tick-borne disease, Death, Control, Congress, CDC, Research, Public, Vaccine

WASHINGTON, Feb. 14, 2024 /PRNewswire/ -- The Center for Lyme Action , a leading nonprofit dedicated to increasing federal funding for Lyme disease research, applauds the new U.S. Department of Health and Human Services National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People (VBD National Strategy) for its emphasis on improving diagnostics and therapies for Lyme and tick-borne disease.

Key Points: 
  • WASHINGTON, Feb. 14, 2024 /PRNewswire/ -- The Center for Lyme Action , a leading nonprofit dedicated to increasing federal funding for Lyme disease research, applauds the new U.S. Department of Health and Human Services National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People (VBD National Strategy) for its emphasis on improving diagnostics and therapies for Lyme and tick-borne disease.
  • The most common vector-borne disease is Lyme disease which has been reported in every U.S. state.
  • "The recently announced Vector-Borne Disease National Strategy is a major milestone which provides a critical roadmap for Congress to direct and fund executive branch actions for prevention, detection, and finding a cure for Lyme and tick-borne conditions,"  said Bonnie Crater, co-founder and board member of Center for Lyme Action.
  • "Center for Lyme Action urges Congress to learn more about the national strategy and continue to prioritize funding for rapid development of reliable and affordable diagnostics and therapies," said Jeff Crater, co-founder and board member of Center for Lyme Action.

The International Lyme and Associated Diseases Society Brings Annual Scientific Conference to Boston

Retrieved on: 
木曜日, 6月 29, 2023
Impact, International Lyme and Associated Diseases Society, Population biology, Practice management software, Pulse, Science, MD, Patient, Tick-borne disease, Encephalopathy, Conference, Content, ILADS, Nursing, Pediatrics

CHEVY CHASE, Md., June 29, 2023 /PRNewswire/ -- The International Lyme and Associated Diseases Society (ILADS) and its foundation, the International Lyme and Associated Diseases Educational Foundation (ILADEF), will welcome its 24th Annual Scientific Conference to Boston, MA.

Key Points: 
  • Highlights Include Expanded Learning Tracks, Enhanced Networking Time, & Refreshed Approach to Content
    CHEVY CHASE, Md., June 29, 2023 /PRNewswire/ -- The International Lyme and Associated Diseases Society (ILADS) and its foundation, the International Lyme and Associated Diseases Educational Foundation (ILADEF), will welcome its 24 th Annual Scientific Conference to Boston, MA.
  • ILADS Scientific Conference is the premier educational experience for healthcare professionals caring for patients with tick-borne disease.
  • "This year's theme is Vector-Borne Diseases: Understanding the Impact of Microbial Communities," says Sarah Quillen, ILADS Executive Director.
  • If you are a member of the media who would like to obtain a press pass, email [email protected] .

Center for Lyme Action Honors Congressional Leaders During Lyme Disease Awareness Month

Retrieved on: 
木曜日, 5月 11, 2023
Disease, Notifiable disease, Lyme disease, Member of Congress, CLA, Norfolk Regional Center, Research, MS, CDC, Congress, Tick-borne disease, Patient, Canine vector-borne disease, Chairperson, Vaccine, Pharmaceutical industry, West Nile virus, Federal

"Lyme is a frustrating and debilitating disease, but it's a solvable problem," said Jeff Crater, co-founder of the Center for Lyme Action.

Key Points: 
  • "Lyme is a frustrating and debilitating disease, but it's a solvable problem," said Jeff Crater, co-founder of the Center for Lyme Action.
  • "Unfortunately, Lyme disease cases are on the rise," Maine Senator Susan Collins told Center for Lyme Action advocates at their annual DC fly-in.
  • The Center for Lyme Action awards build on the momentum of 163% increase in Federal funding for Lyme disease across Federal agencies from $59 million in FY20 to $155.5 million in FY23.
  • Federal funding for Lyme disease continues to be very low at $82 per patient compared with much rarer diseases.

AKC Canine Health Foundation Welcomes Dr. Stephanie Montgomery as Chief Executive Officer

Retrieved on: 
火曜日, 5月 9, 2023
Vaccine, Epilepsy, University, Veterinary medicine, Infection, Cancer, Research, University college, Doctor of Philosophy, Dog, Tick-borne disease, Health, CHF, DVM, North Carolina State University College of Veterinary Medicine, Management, Microbiology, Medicine

RALEIGH, N.C., May 9, 2023 /PRNewswire/ -- The AKC Canine Health Foundation (CHF), a non-profit organization dedicated to advancing the health of all dogs and their owners, welcomes Stephanie Montgomery, DVM, PhD, DACVP as Chief Executive Officer (CEO) starting in June.

Key Points: 
  • RALEIGH, N.C., May 9, 2023 /PRNewswire/ -- The AKC Canine Health Foundation (CHF), a non-profit organization dedicated to advancing the health of all dogs and their owners, welcomes Stephanie Montgomery, DVM, PhD, DACVP as Chief Executive Officer (CEO) starting in June.
  • Dr. Montgomery earned her PhD in Microbiology & Immunology from the University of North Carolina School of Medicine.
  • Dr. Charles Garvin, CHF Board Chairman notes, "We are thrilled to have Dr. Montgomery join the leadership team at CHF.
  • CHF currently manages a portfolio of 170 active canine health research and educational grants studying health topics from epilepsy to cancer to tick-borne disease and more.

University Products Issues Urgent Warning to Cattle Ranchers: 'New Study Reveals High Costs of Acute Anaplasmosis Infections in Beef Bulls'

Retrieved on: 
水曜日, 4月 19, 2023
Infection, BMC Veterinary Research, Universal Product Code, Breeding, Weight loss, Anaplasmosis, Hope, Head, Research, Appetite, Animal, Cattle, Tick-borne disease, DVM, Disease, Beef cattle, Animal husbandry

BATON ROUTE, La., April 19, 2023 /PRNewswire/ -- University Products LLC , a Louisiana-based company, is warning cattle ranchers and beef producers about the adverse breeding outcomes associated with acute anaplasmosis infections.

Key Points: 
  • BATON ROUTE, La., April 19, 2023 /PRNewswire/ -- University Products LLC , a Louisiana-based company, is warning cattle ranchers and beef producers about the adverse breeding outcomes associated with acute anaplasmosis infections.
  • The study also recommends a 90-day or greater retest window for bulls of unsatisfactory breeding potential recently recovered from clinical anaplasmosis.
  • A veterinarian researcher and vaccine developer, this is an issue that Dr. Donald Luther, DVM of University Products understands well.
  • It is vital that cattle ranchers and beef producers take the threat seriously and take measures to protect their herds.

AKC Canine Health Foundation Recognizes 2022 Leaders in Canine Health

Retrieved on: 
月曜日, 12月 19, 2022
American Kennel Club, Legacy Awards (NLBM), Tick-borne disease, Health, AKC, Science, Cancer, Dog, Epilepsy, Kennel club, Orthopedic Foundation for Animals, Organization, Research, British Inspiration Awards, CHF, Azorean Maritime Heritage Society, Charity Navigator, Volunteering, Vaccine

RALEIGH, N.C., Dec. 19, 2022 /PRNewswire/ -- The AKC Canine Health Foundation (CHF), a nonprofit organization dedicated to advancing the health of all dogs and their owners, recognizes the following leaders in canine health with their annual awards.

Key Points: 
  • RALEIGH, N.C., Dec. 19, 2022 /PRNewswire/ -- The AKC Canine Health Foundation (CHF), a nonprofit organization dedicated to advancing the health of all dogs and their owners, recognizes the following leaders in canine health with their annual awards.
  • The Legacy Award is given in special recognition of a lifelong champion for dogs and supporter of the AKC Canine Health Foundation and its mission.
  • The new Inspiration Award is given to honor an individual creatively expanding awareness of the role that the AKC Canine Health Foundation plays in advancing canine health.
  • Since 1995, the AKC Canine Health Foundation has leveraged the power of science to address the health needs of all dogs.

Bacterial Biofilms, Responsible for Up to 75% of All Infectious Diseases in America, Explored in New Webinar From Quidel Corporation

Retrieved on: 
水曜日, 8月 24, 2022
Technology, Infectious Diseases, Hospitals, Software, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Nervous system, COVID-19, University, Human, Exocrine gland, Mucus, Tick-Borne Disease Alliance, Biofilm, Disease, Virulence, Heart, National, Infection, Blood, Point-of-care testing, Tick-borne disease, Physician, Skin, Diagnosis, Degenerative disease, Time-invariant system, Laboratory, Gastrointestinal tract, Cystic fibrosis, Joint, Privacy, Nasdaq, FDA, Prevalence, Chronic Lyme disease, Â, Environment, Bacteria, Patient, Vaccine, Quidel Corporation, Lyme disease

This important medical reality is now being addressed in a new webinar made available by Quidel Corporation, the California-based diagnostic health care manufacturer known for successfully developing rapid diagnostic health solutions.

Key Points: 
  • This important medical reality is now being addressed in a new webinar made available by Quidel Corporation, the California-based diagnostic health care manufacturer known for successfully developing rapid diagnostic health solutions.
  • The webinar, available at https://education.quidel.com/educational-categories , discusses the basics of bacterial biofilms including when and how they develop, its composition and factors that contribute to antibiotic resistance and virulence.
  • The session also explores the biofilms in the context of Lyme disease and the potential link between chronic Lyme and biofilm formation.
  • It is important to understand how these biofilms are formed and their maturation as well as their dispersal.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Research Report 2022 - ResearchAndMarkets.com

Retrieved on: 
金曜日, 6月 3, 2022
Medical Devices, Infectious Diseases, Hospitals, Health, Medical Supplies, Tick-borne disease, Biomarker, LFIA, Company, Food, Infection, Point-of-care testing, POCT, Siemens, A*STAR, Animal, Hologic, Disease, Becton, Dickinson and Company headquarters, University, Blood, Immunoglobulin G, Serum, Method, Immunoglobulin A, Hospital, Coronavirus, Immunoglobulin M, COVID-19, Harvard University, Thermo Fisher Scientific, Antibody, QIAGEN, Toxicology, Severe acute respiratory syndrome coronavirus 2, BioMérieux, SRL Diagnostics, Abbott Laboratories, Pregnancy, Gertrude Pocte Geddes Willis, Asia-Pacific, POC, Danaher Corporation, Application, Fertility, Bio-Rad Laboratories, Ol-molog, Medical device, Oil, Pharmaceutical industry, Vaccine

The "Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • The lateral flow immunoassay (LFIA) based rapid test market consists of sales of devices and equipment used to run lateral flow immunoassays (LFIA) based rapid test and related services by companies that develop lateral flow immunoassays (LFIA) based rapid test equipment.
  • Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
    6.2.
  • Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
    6.3.

Clinically Effective A. Marginale Bovine Vaccine Makes International Research News, Causes Global Excitement for Cattle Ranchers Currently Battling Anaplasmosis Epidemic

Retrieved on: 
水曜日, 6月 1, 2022
Parasitology, Tick-borne disease, PDF, Infection, Veterinary parasitology, Research, LLC, BATON, Anaplasmosis, Animal, Disease, Vaccine, Farmer, Risk, Technology, Health in the Central African Republic, Universal Production Music, Degenerative disease

BATON ROUGE, La., June 1, 2022 /PRNewswire/ -- University Products LLC demonstrated the clinical importance of using a killed A. marginale vaccine, rather than the usual live A. centrale vaccine in the fight against annual bovine anaplasmosis infections – citing recent research published in Veterinary Parasitology. The study analyzed three tick-borne disease strains developed in Australia and imported into Paraguay for analysis – one of which causes anaplasmosis and was treated with a vaccine based on A. centrale. Researchers definitively concluded that: "The A. centrale [vaccine] strain did not prove to be as safe as would be desirable in safety trials, neither did it provide as good protection … an alternative to A. centrale should be sought to provide protection against local strains of A. marginale."

Key Points: 
  • The study analyzed three tick-borne disease strains developed in Australia and imported into Paraguay for analysis one of which causes anaplasmosis and was treated with a vaccine based on A. centrale.
  • marginale."
  • Our killed vaccine is based on Anaplasma marginale and provides superior protection at a lower cost with fewer handling conditions.
  • The University Products vaccine does not prevent infection, but when properly used, significantly reduces clinical signs in at-risk animals.